| 000 | 01772 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250515184757.0 | ||
| 264 | 0 | _c20090928 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0b013e3181b6bbe3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPilotto, Alberto | |
| 245 | 0 | 0 |
_aEffect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease. _h[electronic resource] |
| 260 |
_bNeurology _cSep 2009 |
||
| 300 |
_a761-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
| 650 | 0 | 4 | _aDonepezil |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndans _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aFranceschi, M | |
| 700 | 1 | _aD'Onofrio, G | |
| 700 | 1 | _aBizzarro, A | |
| 700 | 1 | _aMangialasche, F | |
| 700 | 1 | _aCascavilla, L | |
| 700 | 1 | _aParis, F | |
| 700 | 1 | _aMatera, M G | |
| 700 | 1 | _aPilotto, Andrea | |
| 700 | 1 | _aDaniele, A | |
| 700 | 1 | _aMecocci, P | |
| 700 | 1 | _aMasullo, C | |
| 700 | 1 | _aDallapiccola, B | |
| 700 | 1 | _aSeripa, D | |
| 773 | 0 |
_tNeurology _gvol. 73 _gno. 10 _gp. 761-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e3181b6bbe3 _zAvailable from publisher's website |
| 999 |
_c19138004 _d19138004 |
||